Advertisement
Research Article| Volume 22, ISSUE 2, P323-349, May 01, 1996

A COST-EFFECTIVE APPROACH TO THE DIAGNOSIS AND TREATMENT OF FIBROMYALGIA

  • Author Footnotes
    * From the Chronic Pain Service, Charlotte Institute of Rehabilitation, Carolinas Medical Center; and the Midatlantic Center for Pain Medicine, Southeast Arthritis Care Center, Charlotte, North Carolina
    Glenn A. McCain
    Footnotes
    * From the Chronic Pain Service, Charlotte Institute of Rehabilitation, Carolinas Medical Center; and the Midatlantic Center for Pain Medicine, Southeast Arthritis Care Center, Charlotte, North Carolina
    Search for articles by this author
  • Author Footnotes
    * From the Chronic Pain Service, Charlotte Institute of Rehabilitation, Carolinas Medical Center; and the Midatlantic Center for Pain Medicine, Southeast Arthritis Care Center, Charlotte, North Carolina
      Pain and weakness are common complaints in patients presenting to rheumatologists and other musculoskeletal pain experts. Often these patients complain of ill-defined pain that has no specific delineating features. A common reason for specialty referral usually is an abnormal immunologic test on an 'arthritis profile' or an unexpected finding after an imaging procedure. Witness the individual who on complaining of generalized pain, weakness, fatigue, malaise, and failure to thrive undergoes a battery of tests to detect antibodies specific for various autoimmune diseases. Bone scan, MR imaging, CT scan, nerve conduction study, electromyography (EMG), and a trial of high-dose steroids yield conflicting results. The patient and referring physician may be concerned that after such extensive investigation no diagnosis has been forthcoming. It often is obvious to the rheumatologist or other specialist that many of these tests and procedures were unwarranted and could have been obviated by a more frugal approach to the use and interpretation of diagnostic tests.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Rheumatic Disease Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      References

        • Bengtsson A.
        • Bengtsson M.
        Regional sympathetic blockade in primary fibromyalgia [abstract].
        Pain. 1988; 33: 161-167
        • Bennett R.M.
        • Clark S.R.
        • Goldberg L.
        • et al.
        Aerobic fitness in the fibrositis syndrome: A controlled study of respiratory gas exchange and 133 xenon clearance from exercise in muscle.
        Arthritis Rheum. 1989; 32: 454-460
        • Bennett R.M.
        • Gatter R.A.
        • Campbell S.M.
        • et al.
        A comparison of cyclobenzaprine and placebo in the management of fibrositis.
        Arthritis Rheum. 1988; 31: 1535-1542
        • Bibolotti E.
        • Borghi C.
        • Paculli E.
        The management of fibrositis: A double blind comparison of maprotiline, chlorimipramine, and placebo.
        Clinical Trials J. 1986; 23: 269-280
        • Bradley L.A.
        Cognitive behavoural therapy for fibromyalgia.
        J Rheumatol. 1989; 16: 131-136
        • Branco J.
        • Atalaia A.
        Paiva Sleep cycles and alpha-delta sleep in fibromyalgia syndrome.
        J Rheumatol. 1994; 21: 1113-1117
        • Burckhardt C.S.
        • Mannerkorpi K.
        • Hedenberg L.
        • et al.
        A randomized controlled clinical trial of education and physical training for women with fibromyalgia.
        J Rheumatol. 1994; 21: 714-720
        • Campbell S.M.
        • Clark S.R.
        • Tindall E.A.
        • et al.
        Clinical characteristics of fibrositis I. A. 'blinded' controlled study of symptoms and tender points.
        Arthritis Rheum. 1983; 26: 817-824
        • Carette S.
        • McCain G.A.
        • Bell D.A.
        • et al.
        Evaluation of amitriptyline in primary fibrositis.
        Arthritis Rheum. 1986; 29: 655-659
        • Carette S.
        • McCain G.A.
        • Bell D.A.
        • et al.
        Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.
        Arthritis Rheum. 1986; 29: 655-659
        • Caruso I.
        • Sarzi Puttini P.C.
        • Boccassini L.
        • et al.
        Double blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome.
        J Int Med Res. 1987; 15: 154-159
        • Cathey M.A.
        • Wolfe F.
        • Kleinheksel S.M.
        • et al.
        Socioeconomic impact of fibrositis: A study of 81 patients with primary fibrositis.
        Am J Med. 1986; 81: 78-84
        • Clark S.R.
        • Tindall E.A.
        • Bennett R.A.
        A double-blind crossover trial of prednisone versus placebo in the treatment of fibrositis.
        J Rheumatol. 1985; 12: 980-983
        • Cortet B.
        • Houvenagel E.
        • Forzy G.E.
        Evaluation of the effectiveness of serotonin (floxetine hydrochloride) treatment: Open study in fibromyalgia.
        Revue Du Rheumatologie Mal Osteo-Articulaires. 1992; 59: 497-500
        • Deluze C.
        • Bosia L.
        • Zirbs A.
        • et al.
        Electroacupuncture in fibromyalgia: Results of a controlled trial.
        BMJ. 1992; 305: 1249-1252
        • Dinerman H.
        • Goldenberg D.L.
        • Felson D.T.
        A prospective evaluation of 118 patients with the fibromyalgia syndrome: Prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low and Ig deposition at the dermal-epidermal junction.
        J Rheumatol. 1986; 13: 368-373
        • Drewes A.M.
        • Andreasen A.
        • Jennum P.
        • et al.
        Zopiclone in the treatment of sleep abnormalities in fibromyalgia.
        Scand J Rheumatol. 1991; 20: 288-293
        • Felson D.T.
        • Goldenberg D.L.
        The natural history of fibromyalgia.
        Arthritis Rheum. 1986; 29: 1522-1526
        • Finestone D.H.
        Fluoxetine and fibromyalgia.
        JAMA. 1990; 264: 2869-2870
        • Furaccioli G.
        • Chirelli L.
        • Scita F.
        • et al.
        training in fibromyalgia syndrome.
        J Rheumatol. 1987; 14: 820-825
        • Geller S.A.
        Treatment of fibrositis with fluoxitene hydrochloride (prozac).
        Am J Med. 1989; 87: 594-595
        • Goldenberg D.L.
        Treatment of fibromyalgia syndrome.
        Rheum Dis Clin North Am. 1989; 15: 61-67
        • Goldenberg D.L.
        • Felson D.T.
        • Dinerman H.
        A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia.
        Arthritis Rheum. 1986; 29: 1371-1377
        • Granges G.
        • Silko P.
        • Littlejohn G.O.
        Fibromyalgia syndrome—assessment of the severity of the condition 2 years after diagnosis.
        J Rheumatol. 1994; 21: 523-529
        • Hamaty D.
        • Valentine J.L.
        • Howard R.E.
        The plasma endorphin prostaglandin and catecholamine profile in patients with fibrositis treated with cyclobenzaprine and placebo.
        J Rheumatol. 1989; 16: S164-S168
        • Hannen H.C.M.
        • Hoenderdos H.T.W.
        • Van Romunde L.K.J.
        • et al.
        Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia.
        J Rheumatol. 1991; 18: 72-75
        • Hudson J.I.
        • Hudson M.S.
        • Pliner L.F.
        • et al.
        Fibromyalgia and major depressive disorder: A controlled phenomenology and family history study.
        Am J Psychiatry. 1985; 142: 441-446
        • Jaeschke R.
        • Adachi J.
        • Guyatt G.
        • et al.
        Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized controlled trials.
        J Rheumatol. 1991; 18: 447-451
        • Kaplan K.H.
        • Goldenberg D.L.
        • Galvin-Nadeau M.
        The impact of a meditation-based stress reduction program on fibromyalgia.
        Gen Hosp Psychiatry. 1993; 15: 284-289
        • Lautenschager J.
        • Schnorrenberger C.C.
        • Muller W.
        Akupunktur bei generalisierter tendomyopathie Dtsch Zschr Akup. 1989; 6: 122-128
        • Martin L.
        • Edworthy S.M.
        • MacIntosh B.E.
        Is exercise helpful in treatment of fibromyalgia?.
        Arthritis Rheum. 1993; 36: S251
        • McCain G.A.
        Non-medicinal treatments in fibromyalgia.
        Rheum Dis Clin North Am. 1989; 15: 73-90
        • McCain G.A.
        Role of physical fitness training in the fibrositis/fibromyalgia syndrome.
        Am J Med. 1986; 81: 73-77
        • McCain G.A.
        • Bell D.A.
        • Mai F.
        • et al.
        A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of the primary fibromyalgia syndrome.
        Arthritis Rheum. 1988; 31: 1135-1141
        • McCain G.A.
        • Bell D.A.
        • Mai F.M.
        • et al.
        A controlled study of the effects of a supervised cardiovascular fitness program on the manifestations of the primary fibromyalgia syndrome.
        Arthritis and Rheumatism Primary Care Reveiw. 1990; 2: 1-15
        • McCain G.A.
        • Scudds R.A.
        The concept of primary fibromyalgia (fibrositis): Clinical value, relation and significance to other musculoskeletal pain syndromes.
        Pain. 1988; 33: 273-287
        • Mengshoel A.M.
        • Aomnaes H.B.
        • Forre O.
        The effects of 20 weeks of physical fitness in females with fibromyalgia.
        Clin Exp Rheumatol. 1992; 10: 345-349
        • Moldofsky H.
        Rheumatic pain modulation disorder; the relationships between sleep, CNS serotonin and pain..
        in: Critchley M. Friedman A. Headache: and Clinical Concepts. Raven Press, New York1982: 51-57
        • Moldofsky H.
        Sleep-wake mechanisms in fibrositis.
        J Rheumatol. 1989; 16: 47-48
        • Moldofsky H.
        • Lue F.A.
        The relationship of alpha and delta EEG frequencies to pain and mood in 'fibrositis' patients treated with chlorpromazine and L-tryptophan.
        Electroencephalogr Clin Neurophysiol. 1980; 50: 71-80
        • Moldofsky H.
        • Lue F.A.
        Sleep and symptoms in 205 patients vs 876 patients with various sleep disorders.
        Sleep Res. 1992; 2: 203-206
        • Moldofsky H.
        Scarisbrick Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation.
        Psychosom Med. 1976; 38: 35-44
        • Moldofsky H.
        • Scarisbrick P.
        • England R.
        • et al.
        Musculoskeletal symptoms and non-REM sleep disturbance in patients with 'fibrositis syndrome' and healthy subjects.
        Psychosom Med. 1975; 37: 341-351
        • Moldofsky H.
        • Warsh J.J.
        Plasma tryptophan and musculoskeletal pain in non-articular rheumatism.
        Pain. 1978; 5: 65-71
        • Molina E.
        • Cecchettin M.
        • Fontana S.
        Failure of EMG-BF after sham BF training in fibromyalgia.
        Federation Proceedings. 1987; 46: 1357-1361
        • Nichols D.S.
        • Glenn T.M.
        Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with Phys Ther. 1994; 74: 327-332
        • Nielson W.R.
        • Walker C.
        • McCain G.A.
        Cognitive behavioural treatment of fibromyalgia syndrome: Preliminary findings.
        J Rheumatol. 1992; 19: 98-103
        • Quimby L.G.
        • Gratwick G.M.
        • Whitney C.A.
        • et al.
        A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.
        J Rheumatol. 1989; 16: 140-143
        • Reynolds W.J.
        • Moldofsky H.
        • Saskin P.
        • et al.
        The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia.
        J Rheumatol. 1991; 18: 452-454
        • Russell I.J.
        • Fletcher E.M.
        • Michalek J.E.
        • et al.
        Treatment of primary syndrome with ibuprofen and alprazolam: A double-blind, study.
        Arthritis Rheum. 1991; 34: 552-560
        • Russell I.J.
        • Michalek J.E.
        • Flechas J.D.
        • et al.
        Treatment of fibromyalgia with Super Malic: A random, double blind, placebo controlled, crossover pilot study.
        J Rheumatol. 1995; 22: 953-958
        • Santandrea S.
        • Montrone F.
        • Sarzi-Puttini P.
        • et al.
        A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome.
        Journal of International Research. 1993; 21: 74-80
        • Saskin P.
        • Moldofsky H.
        • Lue F.A.
        Sleep and rheumatic pain modulation disorder (fibrositis syndrome).
        Psychosom Med. 1986; 48: 319-323
        • Schakel B.S.
        • Horne J.A.
        The alpha sleep anomaly and related phenomena.
        Sleep Res. 1987; 16: 432-438
        • Scudds R.A.
        • McCain G.A.
        • Rollman G.B.
        • et al.
        Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline.
        J Rheumatol. 1989; 16: 113-119
        • Scudds R.A.
        • Trachsel L.C.E.
        • Luckhurst B.A.
        • et al.
        A comparative study of pain, sleep quality and pain responsiveness in fibrositis and myofascial pain syndrome.
        J Rheumatol. 1989; 16: 120-126
        • Silverman S.L.
        • Wallace D.J.
        Calcitonin helps a subset of patients with fibromyalgia.
        Arthritis Rheum. 1991; 34: R21
        • Simms R.W.
        • Gunderman J.
        • Howard F.
        • et al.
        The alpha-delta sleep anomaly in fibromyalgia.
        Arthritis Rheum. 1988; 31: 100
        • Simons D.G.
        Myofascial pain syndromes: Where are we?.
        Where are we going? Arch Phys Med Rehabil. 1988; 69: 207-212
        • Simons D.G.
        • Travell J.G.
        Myofascial origins of low back pain. I. Principles of diagnosis of treatment.
        Postgrad Med. 1983; 73: 68-77
        • Stratz T.
        • Menne T.
        • Benn H.P.E.
        Blocking of S2 receptors: A new treatment principle in generalized tendo myopathy Z Rheumatol. 1991; 50: 21-22
        • Tavoni A.
        • Vitali C.
        • Bombardieri S.
        Evaluation of S-adenosyl-methionine in primary fibromyalgia.
        Am J Med. 1987; 83: 107-110
        • Travell J.G.
        • Simons D.G.
        Myofascial Pain and Dysfunction. The Trigger Point Manual. Williams and Wilkins, Baltimore1983
        • Vaeory H.
        • Abrahamsen A.
        • Forre O.
        Treatment of fibromyalgia (fibrositis syndrome): A parallel double blind trial with paracetamol, and caffeine versus placebo.
        Clin Rheumatol. 1989; 8: 245-250
        • Ware J.C.
        • Russell J.
        Campos Alpha intrusions into the sleep of depressed and fibromyalgia syndrome (fibrositis) patients.
        Sleep Res. 1986; 15: 210
        • Waylonis G.
        Long term followup on patients with fibrositis treated with acupuncture.
        Ohio State Medical Journal. 1977; 73: 299-302
        • Waylonis G.
        Subcutaneous electrical stimulation (acupuncture) in the clinical practice of physical medicine.
        Arch Phys Med Rehabil. 1976; 57: 161-165
        • White K.P.
        • Nielson W.R.
        Cognitive behavioral treatment of fibromyalgia syndrome: A followup assessment.
        J Rheumatol. 1995; 22: 717-721
        • Wilke W.S.
        Treatment of "resistant" fibromyalgia.
        Rheum Dis Clin North Am. 1995; 21: 247-260
        • Wolfe F.
        The clinical syndrome of fibrositis.
        Am J Med. 1986; 81: 7-14
        • Wolfe F.
        Fibromyalgia: The clinical syndrome.
        Rheum Dis Clin North Am. 1989; 15: 1-18
        • Wolfe F.
        • Cathey M.A.
        • Kleinheksel S.M.
        Fibrositis (fibromyalgia) in rheumatoid arthritis.
        J Rheumatol. 1984; 11: 814-818
        • Wolfe F.
        • Cathey M.A.
        • Kleinheksel S.M.
        • et al.
        Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis.
        J Rheumatol. 1984; 11: 500-506
        • Wolfe F.
        • Hawley D.J.
        • Cathey M.A.
        • et al.
        Fibrositis: Symptom frequency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 598 normal individuals.
        J Rheumatol. 1985; 12: 1159-1163
        • Wolfe F.
        • Simons D.G.
        • Fricton J.R.
        • et al.
        The fibromyalgia and myofascial pain syndromes: A preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease.
        J Rheumatol. 1992; 19: 944-951
        • Wolfe F.
        • Smythe H.A.
        • Yunus M.B.
        • et al.
        The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee.
        Arthritis Rheum. 1990; 33: 160-172
        • Wysenbeek A.J.
        • Nor F.
        • Lurie T.
        • et al.
        Imipramine for the treatment of fibrositis: A therapeutic trial.
        Ann Rheum Dis. 1985; 44: 752-753
        • Yunus M.B.
        • Kalyan-Raman V.P.
        Muscle biopsy findings in primary fibromyalgia and other forms of nonarticular rheumatism.
        Rheum Dis Clin North Am. 1989; 15: 115-134
        • Yunus M.B.
        • Masi A.T.
        • Aldag J.C.
        A controlled study of primary fibromyalgia syndrome: Clinical features and association with other functional syndromes.
        J Rheumatol. 1989; 16: 62-71
        • Yunus M.B.
        • Masi A.T.
        • Calabro J.J.
        • et al.
        Primary (fibrositis): Clinical study of 50 patients with matched normal controls.
        Semin Arthritis Rheum. 1981; 11: 151-171